Secondary analysis reveals limited diagnostic accuracy for early pregnancy HbA1c screening in pregnant women, suggesting that standard oral glucose tolerance testing remains necessary.
Background: Early pregnancy HbA1c has been proposed as a simple screening tool to reduce the need for oral glucosetolerance testing (OGTT). This study evaluated previously proposed HbA1c rule-out and rule-in thresholds in an Indianhospital population. Materials and Methods: This secondary analysis included 100 pregnant women. First-trimester HbA1cwas evaluated against recorded GDM and reconstructed IADPSG positivity. Diagnostic performance was assessed at HbA1cthresholds from 4.9% to 6.5%. A two-threshold strategy using <4.9% for rule-out, 4.9–5.39% as the OGTT zone and ≥5.4%for rule-in was also assessed. ROC analysis was performed. Results: HbA1c showed modest discrimination for recordedGDM (AUC 0.635, 95% CI 0.524–0.747) and poor discrimination for IADPSG positivity (AUC 0.518, 95% CI 0.395–0.642). At ≥4.9%, sensitivity and specificity for recorded GDM were 76.1% and 37.0%, respectively. The two-thresholdstrategy classified 31 women as rule-out, four in the OGTT zone and 65 as rule-in. Although OGTT could theoretically beavoided in 96%, 11 women with recorded GDM and 21 IADPSG-positive women were present in the rule-out group.Conclusion: Early pregnancy HbA1c showed limited stand-alone screening performance. The proposed two-thresholdstrategy reduced theoretical OGTT requirement but resulted in substantial misclassification. External validation is requiredbefore such thresholds are used in routine practice.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: